COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review

Although the possibility of asymptomatic course for COVID‐19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID‐19 is important as the progression is still not clear. Although the possibility of asymptomatic course for COVID‐19 infection in splenectomize...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2020-12, Vol.8 (12), p.2918-2922
Main Authors: Okar, Lina, Ali, Mohammad, Parengal, Jabeed, Yassin, Mohamed A.
Format: Article
Language:English
Subjects:
Anemia
Asymptomatic
Blood diseases
blood transfusion
Blood transfusions
Bone marrow
Case Report
Case Reports
Chelation therapy
Coronaviruses
COVID-19
Disease transmission
Epidemics
Hemoglobin
hemoglobinopathies
Infections
Iron
iron chelation therapy
Laboratories
Literature reviews
Middle East respiratory syndrome
Mortality
Pandemics
Patients
Respiratory diseases
Severe acute respiratory syndrome coronavirus 2
splenectomy
thalassemia beta major
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although the possibility of asymptomatic course for COVID‐19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID‐19 is important as the progression is still not clear. Although the possibility of asymptomatic course for COVID‐19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID‐19 is important as the progression is still not clear.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3345